drugset / Trial / NCT02108223
The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI
Phase 4
Completed
137 enrolled
Sisli Hamidiye Etfal Training and Research Hospital
Selcuk University · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The investigators aimed to evaluate patients who had In-vitro fertilization treatment and who had COH (controlled ovarian hyperstimulation) cycles applying long protocol with GnRH (gonadotropin-releasing hormone) analogue with suboptimal response to the rFSH. The investigators evaluated and compared the addition of rLH, increasing the dose of rFSH and the control groups regarding the results of IVF in these patients.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gonal-f | Protein / enzyme biologic | 75 unknown | — |
| Comparator | Lutropin alpha | Protein / enzyme biologic | 75 iu | — |